ALEXANDRIA, Virginia, Oct. 22 [Category: Medical] -- The American Association for the Study of Liver Diseases posted the following news:

* * *

AASLD and AGA Offer First Medication-focused Guideline for Treating PBC

*

Peroxisome proliferator-activated receptor agonists are suggested as second-line therapy for patients with primary biliary cholangitis (PBC) who do not respond adequately to or are intolerant of ursodeoxycholic acid.

B . . .

Click here for more information about our products